Physicians Symposium
MULTIPLE MYELOMA: CHANGING & EMERGING TREATMENT PARADIGMS – Kenneth Anderson, MD
STATE OF THE ART: 2019 EMERGING THERAPIES IN HEMATOLOGIC MALIGNANCIES – Ruemu E. Birhiray, MD
NOT SO BENIGN HEMATOLOGY: COMPLEMENTOPATHIES AND APLASTIC ANEMIA – Robert Brodsky, MD
INDOLENT LYMPHOMAS AND HODGKIN’S LYMPHOMA: ACHIEVING CURABILITY – Bruce Cheson, MD, FACP, FAAS, FASCO
HEMATOPOIETIC STEM CELL TRANSPLANTATION: HOW I TREAT AND WHEN I TRANSPLANT IN 2019
– Richard Childs, MD, RADM, USPHS
– Richard Childs, MD, RADM, USPHS
PRACTICAL CONSIDERATIONS IN THE TREATMENT MYELOPROLIFERATIVE NEOPLASMS: PROGNOSTIFICATION AND CURRENT TREATMENT
– Angela Fleischman, MD, PhD
– Angela Fleischman, MD, PhD
ACUTE LYMPHOBLASTIC LEUKEMIA: EMERGING AND TARGETED THERAPIES
– Hagop Kantarjian, MD
– Hagop Kantarjian, MD
BENIGN HEMATOLOGY: CYTOPENIAS, CLOTTING, AND BLEEDING – Craig Kessler, MD
CHRONIC MYELOID LEUKEMIA: TARGETED THERAPY IN 2019 – Richard Larson, MD
AGGRESSIVE B AND T CELL LYMPHOMAS: CHEMOTHERAPY, ANTIBODIES, IMMUNOTHERAPY – John Leonard, MD
MYELODYSPLASTIC SYNDROME; HOW MUCH FURTHER DO WE HAVE TO TRAVEL?
– Richard Stone, MD
– Richard Stone, MD
ACUTE MYELOID LEUKEMIAS: TREATMENT OPTIONS IN 2019
– Martin Tallman, MD
– Martin Tallman, MD
GENOMIC BASED TREATMENT OF WALDENSTRÖM’S MACROGLOBULINEMIA
– Steven Treon, MD, MA, PhD, FACP, FRCP
– Steven Treon, MD, MA, PhD, FACP, FRCP
CHALLENGING CASES PRESENTATION
– Michael C. Wiemann, MD, FACP – Co-Chair
– Michael C. Wiemann, MD, FACP – Co-Chair
CHRONIC LYMPHOCYTIC LEUKEMIA: HOW TO TREAT IN 2019 – Jennifer Woyach, MD
T. HOWARD LEE KEYNOTE LECTURE: EMERGING TARGETED THERAPIES FOR FOLLICULAR LYMPHOMAS: A FUTURE WITHOUT CHEMOTHERAPY – Pier Zinzani, MD, PhD
Nursing Symposium
INDOLENT LYMPHOMAS AND HODGKIN’S LYMPHOMA – Bruce Cheson, MD, FACP, FAAS, FASCO
MYELOPROLIFERATIVE NEOPLASMS – Angela Fleischman, MD, PhD
HOW I TREAT MULTIPLE MYELOMA – Morie Gertz
BENIGN HEMATOLOGY AND COAGULOPATHY – Craig Kessler, MD
MANAGEMENT OF LONG-TERM SURVIVORS OF HEMATOLOGIC MALIGNANCIES – Kristi Orbaugh, RN, MSN RNP, AOCN
MANAGING DRUG INTERACTION WITH ORAL ONCOLYTICS IN THE MANAGEMENT OF HEMATOLOGIC MALIGNANCIES
– David Reeves, PharmD, BCOP
– David Reeves, PharmD, BCOP
AGGRESSIVE LYMPHOMAS – Sonali Smith, MD
ACUTE LEUKEMIA AND MDS – Richard Stone, MD
CHRONIC LEUKEMIAS – Jennifer Woyach, MD
RECOGNITION AND MANAGEMENT OF TOXICITIES OF ORAL THERAPEUTICS IN HEMATOLOGIC MALIGNANCIES
– Michelle Wright Mast, FNP-BC
– Michelle Wright Mast, FNP-BC